Navigation Links
Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
Date:9/9/2008

Clinical Trial Programs Funded Through 2009

SAN FRANCISCO, Sept. 9 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biopharmaceutical company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced the closing of a financing transaction with gross proceeds of $8.3 million USD, exceeding the target of $8 million USD. The offering was completed without the services of an agent.

The net proceeds of the private placement will be used to advance the Company's clinical development programs, including lead product JX-594, which is currently being evaluated in a randomized Phase II clinical trial for liver cancer. This is one of three clinical trials currently under way, which also include a Phase II trial for colon cancer and a Phase I trial targeting lung cancer and other solid tumors. Proceeds from the financing will also be used for research and development, general corporate purposes and to augment working capital.

"We are extremely pleased by the enthusiastic support of existing shareholders, and we welcome several new shareholders to the Company," said David H. Kirn, M.D., President and CEO of Jennerex. "This funding is expected to cover operations for the next 18 months, through the end of 2009, and specifically to fund the company through significant value inflection points, including completion of the above-mentioned clinical trials," said Dr. Kirn.

Jennerex also announces the appointment of Calvin Stiller, CM, O. ONT, MD, F.R.C.P. (C) to the Company's Board of Directors. Dr. Stiller is Chairman of the board and Chief Executive Officer of Stilco Corporation and BioQuest Innovations Inc. Dr. Stiller has also served as a director of NPS Pharmaceuticals Inc. since December 1999; and had served on the board of Allelix since April 1999 until its acquisition by NPS. From 1996 to 2005, Dr. Stiller served as Chairman and Chief Executive Offi
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
2. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
3. Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol
4. Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
5. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
6. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
7. Renowned NJ-Based Video Assisted Thoracic Surgery (VATS) Team Completes 5,000th Successful Procedure
8. BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial
9. Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
10. NuVasive Completes Acquisition of Osteocel Biologics Business
11. Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Austria, November 9 For more than... working on the development of a,Brain-Computer In...nel,between the brain and a computer. Such a syste...cate or to control devices in their environment ju...patients have been supervised by,the researchers t...
(Date:11/9/2009)... Four of the top 10 pharmaceutical giants use D...to Health Canada. Datafarm’s announcement co... DIA Annual Meeting where Health Canada stated tha...bmit Hybrid eCTD regulatory submissions for New Dr...mission request. , Marlbo...
(Date:11/8/2009)..., Calif. Nov. 5, 2009 Complete Genomics, a third... announced publication of a report in the journal ...g platform, including analysis of sequence data fr...ost for these three genomes sequenced on the proof...8,005 for 87x coverage to $1,726 for 45x coverage ...
(Date:11/6/2009)... Nov. 6 Helix BioPharma ... announced that John Docherty, president and chief...n Ford,s 6th annual Investor Summit on November 10... City. Mr. Docherty will provide an overview of t...L-DOS47 and Topical Interferon Alpha-2b. The slid...
Breaking Biology Technology:intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3
...IRVINE, Calif., July 31 Alsius Corporation,(Nasda...temperature,management (IVTM(TM)) therapies for cr...l hold a conference call to discuss the Company,s,...ate. Bill Worthen,president and CEO, will host the...m. Eastern Time) on Thursday, August 7. A press re...
...Raises Full Year Financial Outlook, MELVILLE, N.Y... GTIV ), the nation,s leading provider of,compreh... second quarter,results, led by double-digit incre...mpany,s Home Health segment., (Logo: http://www....Performance highlights for the quarter ended June ...
..., Murray Grossan, MD (cre...escribes his successful treatment protocol for app...ories directly into the sinus cavities using a pul...extremely helpful for his patients who experience ...nea., http://abclocal.go.com/kabc/story?section=ne...
Other Biology Technology:Alsius Corporation to Host Second Quarter 2008 Financial Results Conference Call on August 7 2Gentiva Reports Strong Second Quarter led by Home Health Segment 2Gentiva Reports Strong Second Quarter led by Home Health Segment 3Gentiva Reports Strong Second Quarter led by Home Health Segment 4Gentiva Reports Strong Second Quarter led by Home Health Segment 5Gentiva Reports Strong Second Quarter led by Home Health Segment 6Gentiva Reports Strong Second Quarter led by Home Health Segment 7Gentiva Reports Strong Second Quarter led by Home Health Segment 8Gentiva Reports Strong Second Quarter led by Home Health Segment 9Gentiva Reports Strong Second Quarter led by Home Health Segment 10Gentiva Reports Strong Second Quarter led by Home Health Segment 11Gentiva Reports Strong Second Quarter led by Home Health Segment 12Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation 2
(Date:11/4/2009)... , Vancouver, BC - Lowly bacteria, it turns out, ...nufacturing plants around the world clean up toxic...mines, specifically RDX, were invented back in Wor... for decades. These high-energy compounds are oft...powerful version of TNT. , But with increased ...
(Date:11/4/2009)... , The University of Oklahoma at Norman has recei...hree funding agencies as part of the federal stimu...funding received by OU researchers to $23 million....or research ranging from archaeology to weather. ,...ystematic approach to matching areasof scholarly e...
(Date:11/4/2009)... , MADISON, N.J., Oct. 20 /PRNewswire-FirstCa...), the world,s leading provider of diagnostic test...the third quarter ended September 30, 2009, income...or $1.02 per diluted share, from $160 million, or ...2008. In 2008, third quarter results were reduced ...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 57017 1Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 57017 2Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 57017 3Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 57017 4NCCN Holds Oncology Research Best Practices Conference 57014 1NCCN Holds Oncology Research Best Practices Conference 57014 2NCCN Holds Oncology Research Best Practices Conference 57014 3CBC Announces Its Cosmetic Bootcamp University Program is Sold Out for New York 57011 1
...k Ridge, Ill. (December 16, 2008) A study recentl...1) estimates that eating one egg per day is respon...ary heart disease (CHD) in healthy adults. Alterna...king, obesity and physical inactivity contribute 3...n gender. This study adds to more than thirty year...
...e firemen fighting fire with fire, researchers at ...assachusetts at Amherst have found a way to fool a...g its own death. , "The basic idea is for an anti...in order to gain immunity, would require the bacte...id Gerard Wong, a professor of materials science a...
...HAM, N.C.Neuroscientists from Duke University Medi...heir brains differently than younger people when i...sociated with negative emotions. , The study, ap...cal Science , is a novel look at how brain connect...e 70, and younger adults, average age 24, were sho...
Other Biology News:New study 'pardons' the misunderstood egg 2New study 'pardons' the misunderstood egg 3Scientists fool bacteria into killing themselves to survive 2Old and young brains rely on different systems to remember emotional content 2
...ains 400 unique human proteins on a 1x3 inch nitro...s section of all cellular proteins, are arrayed in...l control proteins and a specific chip layout guar... protein microarrays are high-density protein bioc...
Product Quotation Request - Microarray Spotting Solution for Silane Coated Slides from Sigma-Aldrich
...analytical performance , When you require ease-...e, the Varian 810-MS delivers., Varian 810-M...terface/extraction optics minimize,interferences...ification. , Optimized sample introduction syst...
...-2000, except that it uses a deep-UV deuterium bul...nd comes with a shutter (controlled via a TTL sign...ungsten Halogen Light Source combines the continuo...t sources in a single optical path. The combined-s...
Biology Products: